Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Sznol

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
Cancer Journal (Sudbury, Mass.)|November 9, 2000
T-cell adoptive immunotherapy: moving ahead by going in a circleM Sznol
Current Opinion in Investigational Drugs (London, England : 2000)|January 5, 2002
Immunotherapy for cancer: focusing on developing treatments rather than drugsM Sznol
Seminars in Oncology|April 1, 1997
Antigen-specific agents in developmentM Sznol, J Holmlund
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 11, 2020
Revisiting anti-CTLA-4 antibodies in combination with PD-1 blockade for cancer immunotherapyM Sznol, I Melero
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1996
Immune monitoring of cancer vaccines. Report on a workshop held at the 9th NCI-EORTC Symposium on New Drugs in Cancer TherapyM Sznol, H Zwierzina
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1993
Adoptive immunotherapyM Sznol, W J Urba
Seminars in Oncology|February 1, 1993
Chemotherapy drug interactions with biological agentsM Sznol, D L Longo
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1991
Adoptive cellular therapyM Sznol, W J Urba
Blood|April 15, 1994
Interleukin-2 in therapy of hematologic malignanciesM Sznol, D R Parkinson
Seminars in Oncology|February 1, 1995
High-dose interleukin-2 in the therapy of metastatic renal-cell carcinomaD R Parkinson, M Sznol
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Cancer Journal (Sudbury, Mass.)|November 9, 2000
T-cell adoptive immunotherapy: moving ahead by going in a circleM Sznol
Current Opinion in Investigational Drugs (London, England : 2000)|January 5, 2002
Immunotherapy for cancer: focusing on developing treatments rather than drugsM Sznol
Seminars in Oncology|April 1, 1997
Antigen-specific agents in developmentM Sznol, J Holmlund
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 11, 2020
Revisiting anti-CTLA-4 antibodies in combination with PD-1 blockade for cancer immunotherapyM Sznol, I Melero
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1996
Immune monitoring of cancer vaccines. Report on a workshop held at the 9th NCI-EORTC Symposium on New Drugs in Cancer TherapyM Sznol, H Zwierzina
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1993
Adoptive immunotherapyM Sznol, W J Urba
Seminars in Oncology|February 1, 1993
Chemotherapy drug interactions with biological agentsM Sznol, D L Longo
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1991
Adoptive cellular therapyM Sznol, W J Urba
Blood|April 15, 1994
Interleukin-2 in therapy of hematologic malignanciesM Sznol, D R Parkinson
Seminars in Oncology|February 1, 1995
High-dose interleukin-2 in the therapy of metastatic renal-cell carcinomaD R Parkinson, M Sznol
Pageof 7